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T
he small GTPases RalA and RalB
are activated downstream of onco-
genic Ras. While activation of RalA is
critically important for tumor initiation
and growth of Ras-driven cancers, the
highly similar small GTPase RalB is
implicated in cell survival and metastasis.
This difference in function between
these two related proteins maps to the
C-terminus, a 30 amino acid region that
regulates subcellular localization and con-
tains several potential phosphorylation
sites. Here we discuss our recent evidence
that phosphorylation by the mitotic
kinase Aurora A promotes RalA relocali-
zation to mitochondrial membranes,
where it recruits the effector RalBP1
and the large dynamin-related GTPase
Drp1 to promote mitochondrial fission.
As upregulation of both RalA and Aurora
A have been observed in human tumors,
and phosphorylation of RalA at the site
targeted by Aurora A promotes tumor-
igenesis, it is possible that regulation of
mitochondrial fission is one mechanism
by which RalA promotes cancer.
Mutations in the RAS gene are present in
nearly one third of all human cancers
and up to 90% of pancreatic cancers.
1
Constitutively active Ras proteins promote
tumorigenesis through the engagement of
downstream effector proteins, including
phosphatidylinositol-3 kinase (PI3K),
2 the
Raf family of serine/threonine kinases,
3-6
and the RalGEF family of guanine nucleo-
tide exchange factors.
7-9 Of these three, the
RalGEF pathway is the least well under-
stood, although mounting evidence points
to a role for this pathway in multiple
aspects of tumorigenesis.
10-18 RalGEFs
comprise a family of six guanine nucleotide
exchange factors (RalGDS, RGL, RGL2/
Rlf, RGL3, RalGPS1 and RalGPS2) of
which all but RalGPS1 and RalGPS2 are
directly activated by Ras.
19 These proteins
promote the activation of two nearly
identical small GTPases, RalA and RalB,
which in turn engage a diverse set of
downstream effector molecules, including
the exocyst components Sec5
20,21 and
Exo84,
22 the large multifunctional RalBP1
(RLIP76/RLIP1/RIP1),
23 the actin cross-
linking protein filamin,
24 and the transcrip-
tion factor ZONAB.
25 Despite 80%
sequence identity, and near 100% identity
in their effector binding domains,
26 RalA
and RalB promote distinct aspects of
tumor growth downstream of oncogenic
Ras. While RalA has been shown to be
important for tumor initiation and growth,
RalB seems to play more of a role in
promoting survival and metastasis.
13,17,27,28
This difference in function between RalA
and RalB maps to the 30 amino acid
hypervariable C-terminus of the protein, as
replacing this region in RalB with that of
RalA is sufficient to impart both the
polarized membrane delivery function, as
well as transforming activity to RalB.
13,29
The hypervariable regions of RalA and
RalB are both highly basic and have a
conserved CAAX motif that targets the
protein for prenylation, but they otherwise
share little sequence identity.
26 Both
sequence analysis and targeted mutational
analysis of these regions have identified
several putative phosphorylation sites that
are unique to either RalA or RalB.
12,13,30,31
These sites are of particular interest, as
analysis of the related small GTPase KRas
suggests that phosphorylation of the
hypervariable domain can have a profound
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impact on subcellular localization and
protein function.
32 Of the two serine
residues in the RalA C-terminus (S183
and S194) and five threonine or serine
residues in the RalB C-terminus (T178,
S182, S192, S193 and S198), several have
been shown to be targets of phosphoryla-
tion,
12,30,31 with the best-characterized
being S194 of RalA. S194 is phosphoryl-
ated by Aurora A, a kinase activated in
mitosis that is known to be important
for mitotic entry, centrosome duplication
and maturation, bipolar spindle assembly
and cytokinesis,
31,33 and can be dephos-
phorylated by the phosphatase PP2A.
30
Phosphorylation of S194 leads to an
increase in active, GTP-bound RalA and
redistributes the protein from the plasma
membrane to internal membranes.
30,31,34
Furthermore, Aurora A cooperates with
RalA to promote tumorigenesis, and
mutating S194 to alanine or dephos-
phorylating S194 by PP2A inhibits RalA
transforming ability.
30,34
In order to better understand the role of
this phosphorylation, we examined the
specific subcellular localization of RalA in
the presence and absence of ectopic Aurora
A. Similar to what was found for KRas
following its phosphorylation by PKC,
32
immunofluorescence analysis of GFP-
tagged RalA and immunoblot analysis of
biochemically fractionated cells revealed
that a portion of RalA localizes at mito-
chondria or membranes tightly associated
with this organelle. Furthermore, expres-
sion of an active (T288D) mutant of
Aurora A or mutation of RalA-S194 to
Aspartic acid to mimic phosphorylation
increased the amount of RalA in the
mitochondria while inhibition of Aurora
A, or mutation of RalA-S194 to Alanine
had the opposite effect.
35
Analysis of the localization of RalA
at mitochondria also revealed a striking
difference in the morphology of mitochon-
dria in cells with activated Aurora A. While
the majority of cells expressing a vector
control exhibited a mixture of long inter-
connected mitochondria and short punctate
mitochondria, cells expressing active Aurora
A
T288D exhibited a large percentage of small
punctate mitochondria. Cells expressing
the kinase-inactive Aurora
K162R,o nt h e
other hand, exhibited a large percentage of
long interconnected mitochondria.
Mitochondrial morphology is main-
tained through a balance of the opposing
processes of fusion and fission and it has
become clear in recent years that main-
taining this balance is critical to a number
of cellular processes and implicated in a
number of human diseases.
36-38 Given that
Aurora A activity promoted the mitochon-
drial localization of RalA and affected
mitochondrial morphology, we performed
both loss-of-function and gain-of-function
analysis and found that RalA was required
for normal mitochondrial dynamics.
Specifically, Aurora A promoted mito-
chondrial division in a RalA and S194
dependent fashion, and expression of the
phosphomimetic RalA
S194D was sufficient
to induce mitochondrial fragmentation.
Furthermore, phosphorylation of RalA by
Aurora A promoted mitochondrial fission,
as opposed to blocking fusion, and was
accompanied by an increase in the levels of
the large, fission-promoting GTPase Drp1
at the mitochondria.
35
Phosphorylation of RalA on S194 was
previously shown to promote the binding
of RalA to RalBP1 over Sec5 and Exo84.
34
Consistent with this, shRNA-mediated
knockdown of RalBP1 phenocopied the
effects of RalA knockdown on mito-
chondrial morphology, promoting long
interconnected networks. Additionally,
expression of active Aurora A
T288D resulted
in an increase in the levels of RalBP1
associated with the mitochondrial fraction.
This increase in mitochondrial RalBP1
was abrogated by knockdown of RalA,
suggesting that RalA recruits RalBP1 to
mitochondria to promote mitochondrial
fission. Indeed fusion of the C-terminus
of RalA in the S194D phosphomimetic
configuration to RalBP1 was sufficient to
promote both mitochondrial localization
and mitochondrial fission.
35
Mitochondrial fission increases during
mitosis, and is dependent on both the
mitochondrial recruitment and phos-
phorylation of Drp1.
39-41 As Aurora A is
active during mitosis,
42 we tested and
found that the levels of S194-phosphory-
lated RalA were increased in mitotic
HeLa cell extracts when compared with
unsynchronized cells and that this phos-
phorylation was coincident with increased
recruitment of RalA, RalBP1, and Drp1
to mitochondrial membranes at mitotis.
Importantly, knockdown of RalA, RalBP1
or Aurora A led to a decrease in Drp1
recruitment to mitochondria during
mitosis, suggesting that this pathway is
critical for the mitotic mitochondrial
recruitment of Drp1.
During mitosis, Drp1 is also phos-
phorylated on S616 by the mitotic kinase
Cyclin B/CDK1.
31 Previous studies have
shown that RalBP1 binds to Cyclin
B/CDK1 and promotes the phosphoryla-
tion of the protein Epsin to suppress
receptor-mediated endocytosis.
43 We con-
firmed that RalBP1 bound to Cyclin B
and associated with CDK1 kinase activity
in mitotic extracts. Furthermore, similar to
its role with Epsin, RalBP1 promoted
CDK1 phosphorylation of Drp1 in vitro,
and loss of RalBP1, but not RalA, decreased
the levels of S616 phosphorylated Drp1 in
mitotic extracts. Importantly, we detected a
complexincluding RalA,RalBP1,Drp1and
Cyclin B on biochemically enriched mito-
chondrial membranes during mitosis, sug-
gesting a model whereby RalBP1 forms a
complex with Drp1 and Cyclin B/CDK1 to
promote Drp1 phosphorylation and this
complex is recruited to mitochondrial
membranes through the binding to S194-
phosphorylated RalA (Fig. 1).
This model predicts that mitotic mito-
chondrial fission will be disrupted in cells
lacking either RalA or RalBP1. Indeed,
while the mitochondria of scramble control
cells underwent fission during metaphase,
mitochondria remained interconnected in
cells in which either RalA or RalBP1 had
been knocked down by shRNA. The
effects of RalA knockdown were rescued
by expression of an shRNA-resistant wild-
type RalA, but not RalA
S194A, underscor-
ing the importance of this phosphoryla-
tion site for mitochondrial fission.
The loss of mitotic mitochondrial
fission in RalA and RalBP1 knockdown
cells often resulted in mitochondrial bridges
between daughter cells during cytokinesis,
which was associated with a failure to
complete cytokinesis and unequal distribu-
tion of mitochondria to the two daughter
cells. Additionally, knockdown cells exhi-
bited signs of mitochondrial dysfunction,
with decreased levels of ATP and reduced
cell growth over time.
35
Notably, upregulation of Aurora A pro-
tein levels
44,45 and RalA activity
10,11,13,46,47
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has been observed in human cancer cells.
Furthermore, knockdown or inhibition of
Aurora A kinase activity impairs tumor
growth,
48,49 and knockdown or inhibition
of RalA reduces Ras-induced transforma-
tion and tumor growth of multiple cancer
cell lines derived from a diverse set of
cancers.
10,11,13,30,46,47,50-52 Importantly, the
loss of Ras-induced tumor formation
following RalA knockdown can be rescued
in most cells by wildtype, but not an
S194A mutant of RalA, confirming the
importance of Aurora A phosphorylation
for this process.
30,31,34 Maintenance of a
dynamic mitochondrial network has been
shown to be important for several cellular
processes that are also known to be critical
for tumorigenesis, including autophagy
and the cargo-specific clearance of mito-
chondria known as mitophagy,
53-56 apop-
tosis
57-59 and maintenance of metabolic
function.
37,60,61 We have shown that
metabolic function is compromised in
cells lacking RalA and RalBP1, ultimately
leading to diminished cellular growth.
35
Taken together, these data suggest the
intriguing possibility that aberrant activa-
tion and phosphorylation of RalA promote
tumor growth, at least in part, through the
regulation of mitochondrial fission. The
finding that the tumor suppressor p53
regulates mitochondrial fission through
down-regulation of miR-499, which nega-
tively regulates Drp1 expression,
62 suggests
that dysregulated mitochondrial dynamics
might be a general feature of cancer cells
and indeed, analysis of cancer cell lines by
electron microscopy has revealed abnormal
mitochondrial morphologies.
63
It will be interesting to test whether, in
addition to metabolic function, autophagy
and apoptosis are also affected by loss of
RalA and RalBP1, and whether their
restoration can rescue the loss of tumor-
igenesis phenotype characteristic of RalA
inhibition. Intriguingly, RalB has been
shown to directly impact both autophagy
64
and apoptosis,
28 through engagement of
Exo84 and Sec5, respectively, however it is
not known how these two related small
GTPases use different effector pathways to
potentially converge on the same cellular
processes and what impact this convergence
may have on Ras-driven tumorigenesis.
If the control of mitochondrial dyna-
mics proves to be important for Ras-driven
tumorigenesis, it could represent an
important step towards discovering a more
effective way to treat cancer. While
inhibition of Ras or other small GTPases
has proven to be problematic as a thera-
peutic strategy,
65 perhaps targeted disrup-
tion of mitochondrial dynamics will prove
Figure 1. Ras activation of RalA leads to engagement of multiple effector pathways. The RalGEF-Ral signaling pathway is a key effector pathway
downstream of activated Ras. Activation of RalA in turn leads to activation of several downstream signaling pathways affecting diverse cellular processes,
including exocytosis, endocytosis, actin dynamics and transcription. New evidence also indicates that following phosphorylation by Aurora A, RalA and its
effector RalBP1 play a key role in the regulation of mitochondrial fission during mitosis by regulating the phosphorylation of Drp1 and its recruitment to
mitochondrial membranes. “*” denotes proteins whose expression or activity have been reported to be elevated in human cancer.
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more pharmacologically feasible. Small
molecule inhibitors of the mitochondrial
fusion and fission machinery, including
the recently described Drp1 inhibitor
Mdivi-1,
66 are under development,
67 and
it will be enlightening to test them in
mouse tumor models to see if they have a
clinical effect on tumor growth.
In conclusion, the finding that phos-
phorylation of RalA promotes mitochon-
drial fission through the recruitment of
RalBP1 and Drp1 to mitochondria repre-
sents an important step forward in our
understanding of RalA function, in
the functional differences between RalA
and RalB, and provides potential insight
into how RalA regulates Ras-mediated
tumorigenesis.
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